• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (56287019)   Find a Category (125)   Find a Journal (6126)   Find a Contributing Scholar (3546)   Find an Academic Assistant (18)
Find an Article PDF (4681874)   Today's Articles (1529)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Article Type
Show more   Refine
For: Comaru-Schally DM. Les antagonistes de la GnRH et l'hyperplasie bénigne de la prostate. ACTA ACUST UNITED AC 2005;39 Suppl 3:S73-7. [PMID: 16302715 DOI: 10.1016/s0003-4401(05)80012-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Number Cited by Other Article(s)
1
Hashim H, Abrams P. Emerging drugs for the treatment of benign prostatic obstruction. Expert Opin Emerg Drugs 2010;15:159-74. [DOI: 10.1517/14728211003716459] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
2
Speakman MJ. Editorial Comment on: Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:178-9. [DOI: 10.1016/j.eururo.2008.03.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA